Anti-PD-L1 antibodies and diagnostic uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10689445
APP PUB NO 20180022809A1
SERIAL NO

15727388

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides programmed death-ligand 1 (PD-L1) antibodies and methods of using the same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • VENTANA MEDICAL SYSTEMS INC.; SPRING BIOSCIENCE CORPORATION

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boyd, Zachary Oakland, US 4 43
Koeppen, Hartmut San Mateo, US 48 686
Kowanetz, Marcin South San Francisco, US 27 140
Liao, Zhiming Livermore, US 22 95
Roche, Patrick C Tucson, US 12 146
Vennapusa, Bharathi Tucson, US 9 72
Zhu, Yifei San Jose, US 24 110

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Dec 23, 2023
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 23, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 23, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00